| Financial Year |
March 31 2023 |
| Monetary Funds |
3,084,030,612.75 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
37,330,054.26 |
| Accounts Receivable |
205,535,653.65 |
| Advances to Suppliers |
102,562,144.55 |
| Other Receivables |
16,124,392.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
370,831,032.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,143,223.89 |
| Total Current Assets |
3,835,557,114.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,217,952,828.36 |
| Under-construction Projects |
489,921,986.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
100,178,292.23 |
| R&D expenses |
-- |
| Goodwill |
37,814,443.78 |
| Long-Term Deferred and Prepaid Expenses |
59,090,176.88 |
| Deferred Income Tax Assets |
32,474,884.00 |
| Other Non-Current Assets |
104,161,885.72 |
| Sub-Total of Non-Current Assets |
2,131,678,452.65 |
| Total Assets |
5,967,235,567.54 |
| Short-Term Loans |
442,784,297.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
61,076,758.69 |
| Accounts Payable |
111,135,253.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
93,839,158.50 |
| Taxes Payable |
52,462,548.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
90,824,294.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,431,748.02 |
| Other Current Liabilities |
914,173.70 |
| Sub-Total of Current Liabilities |
865,500,337.40 |
| Long-term Loans |
207,692,255.74 |
| Bonds Payable |
947,727,476.76 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,314,443,563.49 |
| Total Liabilities |
2,179,943,900.89 |
| Paid-In Capital(Or Share Stock) |
807,711,312.00 |
| Capital Surplus |
679,631,545.81 |
| Surplus Reserve |
403,855,193.00 |
| LESS:Treasury Stock |
509,689,678.79 |
| Undistributed Profits |
2,299,190,939.08 |
| Minority Stockholder's Interest |
14,889,448.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,772,402,218.12 |
| Owner's Equity（Stockholder's Equity） |
3,787,291,666.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,967,235,567.54 |
